DOSINA

2-DPMP

Research chemical

A very potent stimulant that is a NDRI. Developed by Novartis in the 1950s, to treat narcolepsy and ADHD, however dropped when Methylphenidate was produced a few years later, which was seen as superior due to its shorter T½. 2-DPMP Half life 16-20 hours. Warning: subjective reports suggest this drug is caustic to the nasal mucosa and may cause damage to the nasal cavity.

desoxypipradrol2dpmp2-desoxypiperadoldesoxypipradol

Extended library — TripSit data only (PolyForm Noncommercial 1.0.0).

Before you dose

⚠This substance's dose is not reliably weight-scaled - the ranges shown are population figures. Sensitivity varies far more between people than body mass explains.

Dose

Published population range

Threshold1 mg
Light2–3 mg
Common3–4 mg
Strong4–6 mg

No weight-based model. Unknown potency — start far below any published figure.

Check an amount you already have

Expected effects

  • Euphoria
  • Increased energy/alertness
  • Decreased need for sleep
  • Increased sociability
  • Mood lift
  • Increased sexuality
  • Excessive talking
  • Decreased appetite
  • Weight loss
  • Sweating

Harm reduction

  • This entry comes from the extended library: it is a less-studied substance with fewer independent sources.
  • Unknown potency is the main risk with novel substances — start with a fraction of any published figure and never re-dose before the full onset has passed.
  • Test with reagents and, where possible, a lab service. Fentanyl and nitazene contamination is not detectable by eye or by reagent alone.
  • Avoid using alone, and do not combine with other drugs while you are learning how a new substance affects you.

Sources

• TripSit wiki (PolyForm Noncommercial)
https://wiki.tripsit.me

Dosina is educational harm-reduction information, not medical advice. Doses are population ranges from published sources and cannot account for your tolerance, health conditions or what is actually in your substance. Possession and use may be illegal where you live.